Table 2.

Symptoms of dyspepsia and endoscopic signs of gastritis in patients after six months in the treatment (600 mg per day CGNC) and control groups.

Parameters	Group of patients
	CGNC	Control
Number of patients (n)	26	24
Symptoms of dyspepsia, n (% of patients)
Regression	24  (92.3%)∗	3 (12.5%)
No shifts	2  (7.7%)∗	14 (58.3%)
Progression	0∗	7 (29.2%)
Endoscopic signs of gastritis, n (% of patients)
Regression	24  (92.3%)∗	4 (16.7%)
No shifts	2  (7.7%)∗	16 (66.7%)
Progression	0∗	4 (16.7%)

^∗Statistically significant difference between CGNC and control groups, p < 0.05–0.001.